Orchid Pharma Limited
ORCHPHARMA.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$49.91B
Close$
$-163.24
116.6% downside
Current Fair Value
116.6% downsideOvervalued by 116.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $49.91 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.05 |
| Beta | 1.62 |
| Outstanding Shares | 50,719,105 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 575.41 |
|---|---|
| PEG | -734.17 |
| Price to Sales | 5.32 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$3.63
Average shareholder expectationRevenue Estimate
$2.31 B
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$2.50
Average shareholder expectationRevenue Estimate
$3.65 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Orchid Pharma Limited
1,169 employees
CEO: Manish Dhanuka Orchid Pharma Limited is a pharmaceutical enterprise primarily focused on the creation, production, and distribution of various pharmaceutical goods within India. Its offerings include active pharmaceutical ingredients (APIs), bulk pharm...